Protective efficacy of six recombinant proteins as vaccine candidates against Echinococcus granulosus in dogs
Guoqing Shao,Ruiqi Hua,Hongyu Song,Yanxin Chen,Xiaowei Zhu,Wei Hou,Shengqiong Li,Aiguo Yang,Guangyou Yang
DOI: https://doi.org/10.1371/journal.pntd.0011709
2023-10-24
PLoS Neglected Tropical Diseases
Abstract:Cystic echinococcosis (CE) is caused by the infection of Echinococcus granulosus sensu lato ( E . granulosus s.l.), one of the most harmful zoonotic helminths worldwide. Infected dogs are the major source of CE transmission. While praziquantel-based deworming is a main measure employed to control dog infections, its efficacy is at times compromised by the persistent high rate of dog re-infection and the copious discharge of E . granulosus eggs into the environment. Therefore, the dog vaccine is a welcome development, as it offers a substantial reduction in the biomass of E . granulosus . This study aimed to use previous insights into E . granulosus functional genes to further assess the protective efficacy of six recombinant proteins in dogs using a two-time injection vaccination strategy. We expressed and combined recombinant E . granulosus triosephosphate isomerase (r Eg TIM) with annexin B3 (r Eg ANXB3), adenylate kinase 1 (r Eg ADK1) with Echinococcus protoscolex calcium binding protein 1 (r Eg EPC1), and fatty acid-binding protein (r Eg FABP) with paramyosin (r Eg A31). Beagle dogs received two subcutaneous vaccinations mixed with Quil-A adjuvant, and subsequently orally challenged with protoscoleces two weeks after booster vaccination. All dogs were sacrificed for counting and measuring E . granulosus tapeworms at 28 days post-infection, and the level of serum IgG was detected by ELISA. Dogs vaccinated with r Eg TIM&r Eg ANXB3, r Eg ADK1&r Eg EPC1, and r E gFABP- Eg A31 protein groups exhibited significant protectiveness, with a worm reduction rate of 71%, 57%, and 67%, respectively, compared to the control group ( P < 0.05). Additionally, the vaccinated groups exhibited an inhibition of worm growth, as evidenced by a reduction in body length and width ( P < 0.05). Furthermore, the level of IgG in the vaccinated dogs was significantly higher than that of the control dogs ( P < 0.05). These verified candidates may be promising vaccines for the prevention of E . granulosus infection in dogs following two injections. The r Eg TIM&r Eg ANXB3 co-administrated vaccine underscored the potential for the highest protective efficacy and superior protection stability for controlling E . granulosus infections in dogs. Cystic echinococcosis (CE), a neglected parasitic zoonosis of global health significance, poses a persistent threat to humans and imposes substantial economic burdens. Dogs are the main source for human CE infections, although the implementation of praziquantel-based deworming programs targeting dogs, certain regions continue to experience high human CE incidence, highlighting the need for alternative preventive strategies such as dog vaccines. Various recombinant vaccines have exhibited promising efficacy; however, no commercially licensed vaccines are currently available for field use due to two key challenges. Firstly, the existing dog vaccine immunization regimen necessitates three injections to achieve adequate protection. Secondly, the vaccine's protective efficacy displays considerable variability among the dogs in vaccinated groups. To address these limitations, we employed the Escherichia coli expression system to produce six potential vaccine candidates. Additionally, we introduced a novel immune protocol involving a two-protein combined vaccine administered via a two-time injection in dogs. Employing this immunization protocol, the r Eg TIM&r Eg ANXB3 co-administrated vaccine demonstrated exceptional stability, exhibiting minimal standard deviation and resulting in a notable 71% reduction in worm burden. Implementation of this two-protein combined vaccine with only two injections not only mitigates the CE infection risk to human and livestock but also represents the more cost-effective and practical solution ever for dog owners.
tropical medicine,parasitology